Atlas Trials

Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women

Clinical trial NCT01159873 · TERMINATED

Trial details

NCT number
NCT01159873
Sponsor
Cephalon
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Bone LossOsteoporosis
Start date
2010-07-01
Primary completion
2010-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.